To hear about similar clinical trials, please enter your email below
Trial Title:
Using Combine Walking and Elastic Band to Decrease Fatigue
NCT ID:
NCT05696275
Condition:
Cancer Related Fatigue
Conditions: Official terms:
Fatigue
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Supportive Care
Masking:
Single (Outcomes Assessor)
Intervention:
Intervention type:
Behavioral
Intervention name:
exercise
Description:
20-30 minutes of walking and elastic band exercise per day
Arm group label:
exercise
Summary:
This study is expected to propose an industry-university cooperation research case for
the next two years. When cancer patients use ePRO to record subjective fatigue, and smart
watches with 4G communication record objective fatigue, they will be given according to
the patient's current degree of mild, moderate and severe fatigue. Suffer from 'exercise
or activity' advice and lead the implementation of appropriate exercise advice. This
study is expected to design aerobic + anaerobic exercise suitable for mild or moderate
patients, and use the sensor of the smart watch to monitor the effect of exercise and
fatigue. To sum up, the first-year plan is expected to use the established ePRO
electronic records, combined with the LINE communication system, to integrate into a
"cancer-related fatigue electronic registration and care system"; the second-year plan
will integrate objective fatigue classifiers, Establish the exercise care option in the
fatigue care system, and use the smart watch to establish a technology record function of
the exercise process to help track the fatigue level of cancer patients.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
1. age 20 years old;
2. diagnosis of cancer;
3. can continuous wearing bracelet for 14 days or more
Exclusion Criteria:
1. Unclear and unable to answer the questionnaire；
2. Not able to walk；
3. platelet <50,000/mm3；
4. ANC 500/cumm
Gender:
All
Minimum age:
20 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
January 16, 2023
Completion date:
December 31, 2024
Lead sponsor:
Agency:
Taipei Medical University
Agency class:
Other
Source:
Taipei Medical University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05696275
